Market closed today (Weekend) · Prices and yields as of last trading day, 06 Nov 2026
Happy Diwali from all of us at RetailBonds

Cancer Centers of America Private Limited — Bonds

Corporate · Healthcare

Verify this issuer →
Methodology v1.0 Download Report (PDF) Watch
Agency Rating
—
Total Debt Outstanding
₹196 Cr
Across 12 instruments
Active Bonds
12
First Issue
28 Feb 2022
Latest Issue
3 Jul 2026
Maturity Range
2030 - 2034
Observation
12 active bonds tracked from this issuer.
View details →
Coverage: Low Data Quality: Low Sources: NSE, BSE, SEBI, rating agencies
Issuer health card 1 item to look at
  • Current ratings No current rating on file
  • Rating direction, 12 months No rating actions on file
  • Watch / negative outlook None in 12 months
  • Issuer not cooperating No such actions in 12 months
  • Rating withdrawn, 12 months No withdrawal of this issuer's rating in 12 months
  • Payment record No payment disclosures since 17 Jul 2026
  • Defaults on record No bond marked defaulted
  • Traded in the last 30 days 0 of 12 active bonds had an exchange trade
  • Exchange filings, 90 days 0 filings on NSE/BSE

A checklist of published facts, not a rating or a view on credit quality. Ratings are the agencies' own; payment record covers NSE disclosures since 17 Jul 2026; "late" means paid more than 3 days after the due date (next-working-day payments are allowed). Rating range covers every current rating on the issuer's active bonds, with each agency's rating date. Rating actions count only when the agency's heading names this issuer, not pools or trusts it originated; a withdrawal is flagged only when the issuer's rating itself is withdrawn, not a single facility. Rating age uses the newest rating date on file and is flagged when older than 12 months. See methodology.

Alert me about Cancer Centers of America Private Limited An email when a rating agency acts on this issuer (including any cut to default grade D) or a payment is disclosed late or short. Free, no account needed.
01 Issuer Overview
Sector
Healthcare
Issuer Type
Corporate
First Tracked Bond
28 Feb 2022
Start of this issuer's debt program timeline
  • 12 active bonds tracked from this issuer.
  • 0 of 12 tracked bonds with a stated security status are secured. (based on 12 bonds with a disclosed security status)

Cancer Centers of America Private Limited, a corporate issuer in the Healthcare sector, is tracked on RetailBonds.in. Outstanding bonds carry a coupon of 0.001%, paid annually. Maturities on outstanding bonds fall between 2030 - 2034.

Data sourced from NSDL, BSE, NSE, and registered credit rating agencies. Verify against the issuer's offer document before transacting.

Thanks — your suggestion has been submitted for review.

02 Debt Profile
Outstanding Bonds
12
Tracked by RetailBonds
Amount Tracked
₹196 Cr
Of bonds tracked by RetailBonds — not the issuer's total outstanding debt
Avg Coupon
0.001%
Same rate on every bond
Avg Remaining Tenure
5.6 Yrs
Nearest maturity Feb 2030
Secured
0%
0 of 12 bonds with known status
Callable
0
Of 12 bonds

Maturity Profile

Active bonds maturing, by year. Bar height relative to the tallest year (4 bonds).

0 2030: 1 bond, ₹8 Cr tracked, avg coupon 0.00% 1 bond 2030 2031: 4 bonds, ₹64 Cr tracked, avg coupon 0.00% 4 bonds 2031 2032: 2 bonds, ₹27 Cr tracked, avg coupon 0.00% 2 bonds 2032 2033: 4 bonds, ₹83 Cr tracked, avg coupon 0.00% 4 bonds 2033 2034: 1 bond, ₹14 Cr tracked, avg coupon 0.00% 1 bond 2034

Security Type / Instrument Mix

  • NCD 12 bonds · 100% · ₹196 Cr tracked

Funding Evolution

■ Issued that year — Cumulative outstanding (tracked)
2022: ₹8 Cr issued 2022 2023: ₹64 Cr issued 2023 2024: ₹27 Cr issued 2024 2025: ₹83 Cr issued 2025 2026: ₹14 Cr issued 2026 Cumulative: ₹8 Cr Cumulative: ₹72 Cr Cumulative: ₹99 Cr Cumulative: ₹182 Cr Cumulative: ₹196 Cr

Based on 12 of 12 active bonds with a known issue date and issue size.

03 Credit Profile
  • Unrated 12 bonds · 100%

Recent Rating Actions

No rating action history available.

04 Outstanding Bonds View all bonds →
ISIN Bond Name Coupon Rating Maturity YTM Last Trade Details
INE0MCP08014 Cancer Centers of America 0.001% Feb 2030 CCD 0.001% — 2030-02-27 — —
INE0MCP08071 Cancer Centers of America 0.001% Feb 2031 CCD 0.001% — 2031-02-08 — —
INE0MCP08063 Cancer Centers of America 0.001% Mar 2031 CCD 0.001% — 2031-03-05 — —
INE0MCP08089 Cancer Centers of America 0.001% Mar 2031 NCD 0.001% — 2031-03-27 — —
INE0MCP08048 Cancer Centers of America 0.001% Nov 2031 CCD 0.001% — 2031-11-28 — —
INE0MCP08022 Cancer Centers of America 0.001% Mar 2032 CCD 0.001% — 2032-03-21 — —
INE0MCP08030 Cancer Centers of America 0.001% Jun 2032 CCD 0.001% — 2032-06-27 — —
INE0MCP08055 Cancer Centers of America 0.001% Feb 2033 CCD 0.001% — 2033-02-09 — —
INE0MCP08097 Cancer Centers of America 0.001% May 2033 CCD 0.001% — 2033-05-14 — —
INE0MCP08105 Cancer Centers of America 0.001% Sep 2033 CCD 0.001% — 2033-09-22 — —
INE0MCP08113 Cancer Centers of America 0.001% Dec 2033 CCD 0.001% — 2033-12-18 — —
INE0MCP08121 Cancer Centers of America 0.001% Jul 2034 CCD 0.001% — 2034-07-02 — —
Compare (/) Compare Bonds

YTM is the market yield from the latest BSE/NSE trade. It shows “—” when that trade is over 30 days old, the bond is under 30 days from maturity, it is a market-linked debenture, or the price failed our checks (hover the dash for the reason). A coupon is never shown as a yield.

05 Market Activity

No recorded secondary-market trades in the last 30 days.

06 Regulatory Filings

No regulatory filings captured yet for this issuer.

07 Methodology & Data Coverage
DatasetCountFreshness
Credit Ratings (current) 0 —
Rating Actions History 0 —
Secondary-Market Trades 0 —
Reg52(4) Payment Disclosures 0 —

Methodology version 1.0. See full methodology for sources and limitations.

Related Issuers

All issuers →

Disclaimer: This page aggregates publicly available data about Cancer Centers of America Private Limited for informational purposes only. Ratings shown are the opinion of the issuing rating agency and are not buy/sell recommendations. RetailBonds.in does not issue its own ratings or investment advice. Verify all data against the issuer’s offer document before transacting.